Clincosm LogoSign in Get a demo

non hodgkin lymphoma

Showing 26 - 50 of 127
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Birmingham, Alabama
  • +19 more
Dec 8, 2022

Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)

Recruiting
  • Non Hodgkin Lymphoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Nov 29, 2022

Non Hodgkin Lymphoma Trial in Cleveland (UF-KURE19 CAR-T cells, Fludarabine, Cyclophosphamide)

Recruiting
  • Non Hodgkin Lymphoma
  • UF-KURE19 CAR-T cells
  • +2 more
  • Cleveland, Ohio
  • +1 more
Nov 21, 2022

Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)

Recruiting
  • Nasopharyngeal Carcinoma
  • +8 more
  • Springdale, Arkansas
    Highlands Oncology
Nov 11, 2022

Multiple Myeloma, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in United States (PRT1419)

Completed
  • Multiple Myeloma
  • +3 more
  • Denver, Colorado
  • +4 more
Nov 14, 2022

Non Hodgkin Lymphoma Trial in San Francisco (Neuropsychological testing)

Not yet recruiting
  • Non Hodgkin Lymphoma
  • Neuropsychological testing
  • San Francisco, California
    Stanford Cancer Center
Nov 9, 2022

B-cell Lymphoma, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial (BN301)

Not yet recruiting
  • B-cell Lymphoma
  • +4 more
  • (no location specified)
Nov 9, 2022

Solid Tumor, Adult, Acute Myeloid Leukemia, MDS Trial in India (AUR103)

Recruiting
  • Solid Tumor, Adult
  • +3 more
  • Surat, Gujarat, India
  • +5 more
Oct 31, 2022

Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

Not yet recruiting
  • COVID-19
  • +2 more
    • Cologne, NRW, Germany
      University Hospital of Cologne
    Oct 27, 2022

    Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • R-CHOP + acalabrutinib
    • Southampton, Hampshire, United Kingdom
    • +6 more
    Oct 26, 2022

    Auto/Allo Tandem Transplant for Relapsed B-NHL

    Completed
    • Non Hodgkin Lymphoma
    • auto transplant followed by allo transplant
    • (no location specified)
    Oct 24, 2022

    Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)

    Recruiting
    • Breast Cancer
    • Non Hodgkin Lymphoma
    • Middlesbrough, Teesside, United Kingdom
      South Tees Hospitals NHS FT
    Oct 20, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Non Hodgkin Lymphoma Trial in Worldwide (HMPL-523)

    Recruiting
    • Non Hodgkin Lymphoma
    • Anaheim, California
    • +20 more
    Oct 4, 2022

    Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia Trial in Cleveland (Fully human anti CD19 CAR-T

    Recruiting
    • Non Hodgkin Lymphoma
    • +2 more
    • Fully human anti CD19 CAR-T Cell Dose
    • +2 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Oct 4, 2022

    Non Hodgkin Lymphoma, Follicular Lymphoma, Relapsed Follicular Lymphoma Trial in Ostrava-, Oslo (Betalutin)

    Completed
    • Non Hodgkin Lymphoma
    • +2 more
    • Ostrava-, Porubá, Czechia
    • +1 more
    Sep 30, 2022

    Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (tafasitamab, parsaclisib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Non Hodgkin Lymphoma
    • Birmingham, Alabama
    • +49 more
    Sep 21, 2022

    Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

    Not yet recruiting
    • Mature B-Cell Neoplasm
    • +25 more
    • (no location specified)
    Sep 14, 2022

    Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

    Recruiting
    • Mantle Cell Lymphoma
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Sep 13, 2022

    Advanced Solid Tumor, Non Hodgkin Lymphoma Trial in Sarasota, Cincinnati, Nashville (BTX-A51)

    Recruiting
    • Advanced Solid Tumor
    • Non Hodgkin Lymphoma
    • Sarasota, Florida
    • +2 more
    Sep 8, 2022

    Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • +7 more
    • Brussels, Brussel, Belgium
      Uz Brussel
    Sep 2, 2022

    Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • UCD19 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    Haematological Malignancy, Acute Myeloid Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (CCS1477, Pomalidomide,

    Recruiting
    • Haematological Malignancy
    • +4 more
    • Phoenix, Arizona
    • +14 more
    Aug 22, 2022

    Non Hodgkin Lymphoma Trial in China (Abexinostat)

    Recruiting
    • Non Hodgkin Lymphoma
    • Beijing, China
    • +3 more
    Aug 18, 2022

    Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma Trial in United States (CB-010,

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +6 more
    • CB-010
    • +2 more
    • Scottsdale, Arizona
    • +7 more
    Aug 19, 2022